Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study

BACKGROUND: In October 2012, the Chinese government established maximum retail prices for specific products, including 30 antineoplastic medications. Three years later, in June 2015, the government abolished price regulation for most medications, including all antineoplastic medications. This study...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Guan, Xiaodong, Wushouer, Haishaerjiang, Yang, Mingchun, Han, Sheng, Shi, Luwen, Ross-Degnan, Dennis, Wagner, Anita Katharina
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2019
Soggetti:
Health Policy
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6924745/
https://ncbi.nlm.nih.gov/pubmed/31784440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031658
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi